Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements longevity clinical trial healthy aging healthspan
Approach: macro science with a conceptual twist. Palette: bold color field. Extreme close-up, slightly high three-quarter angle, of a raw salmon fillet's translucent coral flesh, with a glass pipette releasing a single droplet of pale amber peptide solution onto the muscle fibers. Glistening myotome layers and fine white connective lines are sharp in the foreground, with shallow depth of field melting the rest. The salmon sits on a saturated teal backdrop, so the orange-pink flesh contrasts strongly with it. Soft, large-source studio light from upper left gives crisp specular highlights on the droplet and moist fibers, with gentle neutral shadows. A tiny electric green reflection glints inside the droplet. The mood is precise, fresh and curious, like a food-science lab photograph. Photorealistic, with no text.
Peptides

Salmon Peptides vs Whey: +13% Ferritin in 8 Weeks (14-Person Pilot)

Nova Chen · · 5 min read
#healthy aging #whey protein #salmon peptides #fish protein hydrolysate #bioactive peptides #ferritin #iron metabolism

What if a 12-gram daily scoop of fish-derived peptides moved ferritin, red blood cell count and inflammation markers in ways whey protein did not? That is the headline-grabbing claim from a new pilot trial of a salmon protein hydrolysate called ProGo®. Before anyone rushes to the supplement aisle, here is the catch: it enrolled just 14 people and was industry-sponsored. The results are intriguing, but they are a signal to follow up, not a verdict.

What Are Salmon Peptides (Salmon Protein Hydrolysate)?

A fish protein hydrolysate is made by taking fish protein, in this case Atlantic salmon, and breaking it into smaller fragments with enzymes. This process, called enzymatic hydrolysis, yields a mix of free amino acids, short peptides (typically 2-20 amino acids long) and some larger fragments.

The idea behind bioactive peptides is that certain fragments do more than supply amino acids. Once released, some may interact with receptors, enzymes or gene-expression pathways. Researchers have studied food-derived peptides for blood pressure, glycemic control, antioxidant activity and immune signaling. Which fragments do what depends heavily on the source protein and the specific enzymes used, so one hydrolysate cannot be assumed to behave like another.

ProGo® is a proprietary salmon hydrolysate from Norway's Hofseth BioCare. Earlier work on the ingredient has pointed to effects on iron metabolism, inflammation and metabolic health, and the ferritin effect has been linked to upregulation of the FTH1 gene, which encodes a ferritin subunit. The ingredient also carries a Health Canada claim related to ferritin and hemoglobin.

The Study: 12 g/Day vs Whey for 56 Days

Published in Biomedicines (2026) by Currie, Myklebust, Bjerknes and Framroze, the trial was a randomized, double-blind, active-controlled pilot in overweight adults aged 25-65, run in Norway with Hofseth BioCare and the Møre og Romsdal Hospital Trust.

  • Participants: 14 overweight adults
  • Intervention: 12 g/day ProGo® salmon protein hydrolysate
  • Comparator: 12 g/day whey protein isolate, matched for nitrogen (iso-nitrogenous)
  • Duration: 56 days (8 weeks)
  • Primary outcomes: hematological parameters and a composite hair, nail and skin (integumentary) score, with Holm-Bonferroni correction for multiple comparisons
  • Secondary outcomes: body composition, inflammatory cytokines and glucose metabolism

The active control matters. Because whey provided the same amount of nitrogen, any difference is harder to explain as simply "more protein."

The Results: What Changed?

Blood markers

Compared with whey, the salmon group showed significant improvements in hemoglobin (about 4%), red blood cell count (about 7%) and ferritin (about 13%), the figures reported in trade coverage of the paper. Ferritin reflects stored iron, while hemoglobin and red cell count reflect oxygen-carrying capacity. Because these were primary outcomes with multiplicity adjustment, they are the study's most credible findings.

Hair, skin and nails

A composite integumentary score improved in the salmon group. This is a subjective-leaning outcome, so it deserves particular caution, though it was a pre-specified primary endpoint.

Body composition

Secondary analyses showed reductions in percent body fat and BMI, with lean body mass preserved. Preserving lean mass while losing fat is relevant to aging, where muscle loss is a major driver of frailty.

Inflammation and glucose

Pro-inflammatory cytokines fell, as did HbA1c and fasting blood glucose. Whey had minimal effect on any of these outcomes.

Note the distinction: the blood and skin outcomes were primary endpoints; body composition, inflammation and glucose were secondary and should be treated as more exploratory.

Why Might Peptides Act Beyond Basic Nutrition?

The authors argue that results are "consistent with a bioactive rather than a purely nutritional effect." Their reasoning is straightforward: both groups got equal nitrogen, but only one group's markers moved.

Plausible mechanisms, some still speculative, include:

  • Iron handling: Gene-expression effects on ferritin (FTH1) could alter how iron is stored or mobilized.
  • Inflammation signaling: Inflammation raises hepcidin, which blocks iron absorption and release. Lower cytokines could, in theory, improve iron availability and red cell production.
  • Metabolic signaling: Small peptides can influence gut hormones and insulin sensitivity pathways.

The study did not definitively test these mechanisms. Also, salmon hydrolysate could contain trace minerals or other components, and the trial could not isolate which fragment, if any, is responsible.

Practical Takeaways

Dose used: 12 g/day for 56 days. That is the only regimen with data here; more is not known to be better.

Who might be curious:

  • People with low or borderline ferritin, though the participants were not selected for iron deficiency, so it is unknown whether the effect holds in deficient people. Low ferritin needs medical evaluation to find the cause.
  • Older adults concerned with anemia risk, inflammation and muscle preservation, a group not studied here (ages 25-65).
  • Pescatarians or people who want a marine-derived protein option.

How it differs from collagen peptides: Collagen peptides are hydrolyzed from collagen-rich tissues (bovine hides, fish skin and scales) and are mostly studied for skin elasticity, joints and bone. This salmon product is a protein hydrolysate with a different composition and a different evidence base focused on iron markers, inflammation and metabolism. They are not interchangeable.

Cautions: Anyone with fish or seafood allergy should avoid it. People with iron overload conditions such as hemochromatosis, those on blood-related medications, or those managing diabetes should speak to a clinician first, since glucose and iron markers could shift.

The Caveats: Read This Before Buying Anything

  1. Tiny sample. Fourteen participants split across two arms cannot reliably detect real effects or rule out chance, especially for secondary outcomes.
  2. Industry involvement. The study was sponsored by the ingredient's maker. That does not invalidate it, but independent replication is essential.
  3. Short duration. Eight weeks says nothing about long-term safety, durability or clinical outcomes like anemia, fractures or disease risk.
  4. Surrogate markers. Changes in ferritin, cytokines and HbA1c are not the same as better health outcomes.
  5. Overweight population. Results may not generalize to lean, elderly or iron-deficient people.
  6. Subjective endpoint. The hair, skin and nail score is vulnerable to bias, even with blinding.
  7. Mechanism unproven. "Bioactive" is an inference, not a demonstrated mechanism.

The authors themselves call the findings "hypothesis-generating" and say confirmation in larger studies is warranted.

The Bottom Line

Salmon protein hydrolysate is an interesting candidate in the bioactive peptide field, and the whey-controlled design makes the signal more notable than a simple protein-versus-placebo comparison. But with 14 participants and sponsor involvement, this is a starting gun for bigger trials, not a reason to treat salmon peptides as a proven way to raise ferritin or slow aging. If you are worried about iron or blood health, get proper lab work first, and let larger, independent trials settle the rest.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: bold color field. A single AA-style cylindrical battery, shown as a real object with a bare metal cap and a plain unlabeled matte sleeve, stands upright on a glossy surface. It is photographed from a low three-quarter angle against a saturated tomato-red seamless backdrop. The battery is half-filled with a translucent amber liquid that visibly rises inside a clear glass cutaway section. A thin ribbon of electric green light (#00e676) wraps around its base like a charging band. Soft large-softbox light comes from the upper left and produces crisp highlights on the metal and a clean, slightly blurred red reflection beneath it. A second, shorter battery sits out of focus behind, nearly drained and empty, to suggest contrast. The mood is energetic, optimistic and precise, with a tactile product-photography look and shallow depth of field.
supplements

NR + Pterostilbene Lifts NAD+ ~40–90% in Human Trial

BY NOVA CHEN ·

Can a daily capsule of nicotinamide riboside and pterostilbene raise NAD+ in older adults? In the first-in-human NRPT (Basis) trial, 120 people aged 60 to 80 took it for eight weeks. Blood NAD+ rose about 40% at the recommended dose and about 90% at double the dose, and the rise held steady through the study. No serious adverse events were reported. Here is what the numbers show, what the dose takeaways are, and what the study cannot tell you.
A wide, minimalist editorial still life on a soft, warm-gray linen surface lit by gentle diffused morning window light. At center sit two identical small amber glass supplement bottles, one slightly in front of the other, with plain matte cream labels and no readable text. In front of them, two matching shallow ceramic dishes in muted sage green hold identical small ivory capsules. The capsules are nearly indistinguishable, which quietly suggests placebo versus active. Beside the dishes, a few wheat germ grains, a small cluster of aged cheddar-toned cheese shards, and a halved ripe mushroom hint at natural spermidine food sources. They are arranged with careful negative space. On the left, a delicate balance scale in brushed brass sits perfectly level, its two small pans empty and even, as a subtle visual metaphor for "no difference." On the right, a neat open notebook with soft blurred pencil lines and a single sprig of dried eucalyptus lies beside a pair of thin round tortoiseshell reading glasses, suggesting older adults and memory without showing any people. The background is a softly blurred pale oat-colored wall with a long gentle shadow cast diagonally across the scene from a window. The color palette is muted and modern: warm cream, sage green, amber, soft brass, and dusty terracotta accents. Shallow depth of field keeps the bottles and scale crisp while the edges melt into a creamy blur. The mood is calm, thoughtful, and quietly skeptical, like a trendy health and science journal feature. Fine film grain, a subtle matte finish, and a balanced asymmetrical composition leave open space in the upper right for headline overlay. Photographed from a slightly elevated three-quarter angle, high-end editorial photography style.
supplements

Spermidine for Memory? A 12-Month Trial in 100 Older Adults Found No Edge Over Placebo

BY DR. SYNAPSE ·

Spermidine has been hyped as a brain-protecting supplement on the strength of autophagy research and animal studies. The SmartAge trial put it to a rigorous test in 100 older adults with subjective cognitive decline, giving about 0.9 mg per day for 12 months. The primary memory outcome did not beat placebo (difference -0.03; P = .47), and secondary outcomes were also null. Exploratory hints on inflammation and verbal memory remain unconfirmed. Here is what the result means for anyone considering a spermidine supplement, and where the study's limits lie.
A bright, minimalist editorial still life on a pale warm-white stone surface, shot from a slightly elevated three-quarter angle in soft natural window light. At center, a small amber glass supplement bottle with a matte cream label, unbranded, sits beside a few loose white capsules. A pair of weathered hands in a light oatmeal linen sleeve, belonging to an older adult, rests gently near the bottle, with a ceramic mug of tea just out of focus. To the right, a clean glass vial and a delicate glass beaker filled with clear liquid catch the light, hinting at laboratory research without any futuristic touch. A small paper notebook with a handwritten simple line graph rising in a gentle curve lies open nearby, along with a sharpened pencil. Scattered at the edges are soft sprigs of dried eucalyptus and a few pale sage-green leaves, adding an organic note. A faint, abstract molecular diagram printed in muted teal ink on a card leans against the bottle, subtle and graphic. The palette is calm and modern: warm ivory, sage green, soft teal, muted amber, and touches of dusty peach. Long, gentle shadows fall across the surface, and the shallow depth of field blurs the background into creamy neutral tones. The composition leaves generous negative space on the left third for headline text. The overall feel is a trendy health and science journal: clean, airy, trustworthy, and quietly sophisticated, with fine film-like grain and true-to-life color. Ultra-detailed, 16:9 landscape.
supplements

1,000 mg of Nicotinamide Riboside Daily Raised Blood Cell NAD+ by About 60% in Older Adults, Randomized Trial Finds

BY DR. SYNAPSE ·

A 2018 Nature Communications crossover trial tested nicotinamide riboside at 500 mg twice daily (1,000 mg/day) for six weeks in healthy middle-aged and older adults. The supplement was well tolerated and raised NAD+ in blood immune cells by about 60% compared with placebo. Researchers also saw early signals for lower blood pressure and arterial stiffness, which they flagged as ideas for larger trials, not proven benefits. This article explains why NAD+ is thought to fall with age, what the study did, and what it cannot tell us about disease outcomes or longevity.
A wide, softly lit editorial still life on a pale travertine surface. In the center-left, a halved ruby-red pomegranate sits open, its glossy arils spilling in a loose cluster onto the stone. Beside it are a few cracked walnut halves and a small matte ceramic dish holding a pinch of fine cream-colored powder. A single aril catches a bright highlight near the foreground. In the soft-focus background, a sheer linen curtain filters warm morning sunlight, which casts long, gentle shadows across the scene. On the right side, an elegant older woman's hand, seen only from the wrist down, rests lightly on the surface next to a minimalist glass of water. Her skin shows natural texture and warmth. A slim sprig of dried olive branch and a folded sage-green napkin add quiet, organic accents. The palette is restrained and modern: deep garnet red, warm walnut brown, oat beige, soft sage, and creamy off-white. The composition leaves generous negative space on the upper right for title text. The depth of field is shallow, with crisp focus on the pomegranate and a creamy bokeh falloff. The lighting is natural, diffused, and slightly golden, in the style of a high-end wellness magazine or a contemporary science and nutrition journal. The mood is calm, clean, and quietly authoritative. The finish is photographic, with fine grain, subtle matte tones, and a premium editorial feel.
supplements

Urolithin A, the Pomegranate Postbiotic, Triggers a Mitophagy Signature in Older Adults

BY DR. SYNAPSE ·

Urolithin A, a molecule made by gut bacteria from pomegranate and walnut polyphenols, has long rejuvenated muscle in aging animals. The first human trial in older adults found it safe, bioavailable, and able to shift mitochondrial biomarkers at 500 to 1,000 mg a day. The study, backed by the company behind Mitopure, showed a molecular signature of improved mitochondrial health in muscle. But it was small, short, and measured biomarkers rather than strength or longevity. Here is what the data show, who it is aimed at, and where the evidence stops.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文